| 162137 | 162137 | Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma | Completed | No Results Available | Nasopharyngeal Neoplasms | Drug: Gemcitabine|Drug: Oxaliplatin | https://ClinicalTrials.gov/show/NCT00436800 |
| 162121 | 162121 | MVA Post-Event: Administration Timing and Boost Study | Completed | No Results Available | Smallpox | Drug: Placebo (subcutaneous)|Drug: Placebo (scarification)|Biological: Dryvax®|Biological: IMVAMUNE® | https://ClinicalTrials.gov/show/NCT00437021 |
| 162122 | 162122 | Effects of Benfotiamine and AGE on Endothelial Function in People With Diabetes | Completed | No Results Available | Endothelial Dysfunction|Type 2 Diabetes Mellitus | Drug: Benfotiamine 1050mg, 3 days|Behavioral: high-AGE vs. low-AGE meal | https://ClinicalTrials.gov/show/NCT00437008 |
| 162138 | 162138 | Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers | Completed | No Results Available | Venous Thrombosis|Pulmonary Embolism | Drug: Fondaparinux Sodium | https://ClinicalTrials.gov/show/NCT00436787 |
| 162123 | 162123 | Extension From Weekly to Once Every Other Week Darbepoetin Alfa Administration in Subjects With Chronic Kidney Disease Receiving Dialysis | Completed | No Results Available | Chronic Kidney Disease | Drug: Darbepoetin Alfa | https://ClinicalTrials.gov/show/NCT00436995 |
| 162139 | 162139 | Treatment Outcome and Quality of Life in Patients With Pediatric Extra-Cranial Germ Cell Tumors Previously Treated on Clinical Trial CCLG-GC-1979-01 or CCLG-GC-1989-01 | Recruiting | No Results Available | Childhood Germ Cell Tumor|Extragonadal Germ Cell Tumor|Gastrointestinal Complications|Infertility|Long-term Effects Secondary to Cancer Therapy in Children|Neurotoxicity|Ovarian Cancer|Pulmonary Complications|Sexual Dysfunction|Urinary Complications | Procedure: assessment of therapy complications|Procedure: quality-of-life assessment | https://ClinicalTrials.gov/show/NCT00436774 |
| 162124 | 162124 | Evaluation of Triathlon - a New Total Knee Prosthesis System | Recruiting | No Results Available | Total Knee Arthroplasty | Device: Triathlon Knee System | https://ClinicalTrials.gov/show/NCT00436982 |
| 162140 | 162140 | Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors | Active, not recruiting | No Results Available | Unspecified Childhood Solid Tumor, Protocol Specific | Biological: anti-thymocyte globulin|Biological: graft-versus-tumor induction therapy|Biological: sargramostim|Drug: busulfan|Drug: cyclosporine|Drug: melphalan|Drug: methylprednisolone|Other: flow cytometry|Other: immunologic technique|Other: laboratory biomarker analysis|Procedure: allogeneic hematopoietic stem cell transplantation|Procedure: umbilical cord blood transplantation | https://ClinicalTrials.gov/show/NCT00436761 |
| 162125 | 162125 | ORTHOVISC Shoulder RCT | Completed | Has Results | Glenohumeral Osteoarthritis | Device: Orthovisc|Drug: Control|Drug: Control | https://ClinicalTrials.gov/show/NCT00436969 |
| 162141 | 162141 | Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney Disease | Terminated | Has Results | Anemia|Chronic Kidney Disease|Kidney Disease | Drug: Darbepoetin Alfa|Drug: Placebo | https://ClinicalTrials.gov/show/NCT00436748 |
| 162142 | 162142 | Nelfinavir in Treating Patients With Metastatic, Refractory, or Recurrent Solid Tumors | Active, not recruiting | No Results Available | Colorectal Cancer|Gastrointestinal Carcinoid Tumor|Head and Neck Cancer|Islet Cell Tumor|Lung Cancer|Metastatic Cancer|Neuroendocrine Carcinoma of the Skin|Ovarian Cancer|Pheochromocytoma|Sarcoma|Unspecified Adult Solid Tumor, Protocol Specific | Drug: midazolam hydrochloride|Drug: nelfinavir mesylate|Genetic: gene expression analysis|Genetic: polymerase chain reaction|Genetic: protein expression analysis|Other: immunoenzyme technique|Other: immunologic technique|Other: laboratory biomarker analysis|Other: mass spectrometry | https://ClinicalTrials.gov/show/NCT00436735 |
| 162143 | 162143 | Induction Treatment Followed by Immunosuppression Withdrawal in Liver Transplantation: A Comparative Trial | Terminated | No Results Available | Liver Diseases | Drug: ATG (Fresenius Biotech) | https://ClinicalTrials.gov/show/NCT00436722 |
| 162144 | 162144 | Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer | Active, not recruiting | No Results Available | Breast Cancer | Biological: bevacizumab|Biological: pegfilgrastim|Drug: cyclophosphamide|Drug: doxorubicin hydrochloride|Drug: paclitaxel albumin-stabilized nanoparticle formulation|Other: flow cytometry|Other: immunoenzyme technique|Other: immunologic technique|Other: laboratory biomarker analysis|Procedure: adjuvant therapy|Procedure: immunoscintigraphy | https://ClinicalTrials.gov/show/NCT00436709 |
| 162145 | 162145 | Genetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma or Noncancerous Conditions | Active, not recruiting | No Results Available | Neuroblastoma | Genetic: gene mapping|Genetic: polymorphism analysis | https://ClinicalTrials.gov/show/NCT00436696 |
| 162146 | 162146 | Dose Ranging Study of Magnesium Iron Hydroxycarbonate in Haemodialysis Subjects With Hyperphosphataemia | Completed | No Results Available | Chronic Kidney Failure | Drug: Fermagate|Drug: Sevelamer HCl | https://ClinicalTrials.gov/show/NCT00436683 |
| 162147 | 162147 | Phase II Study to Evaluate the Efficacy of AMG 317 | Completed | No Results Available | Asthma | Biological: AMG 317 75 mg|Biological: AMG 317 150 mg|Biological: AMG 317 300 mg|Biological: Placebo | https://ClinicalTrials.gov/show/NCT00436670 |
| 162148 | 162148 | Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer | Completed | No Results Available | Peritoneal Neoplasms|Retroperitoneal Neoplasms|Gastrointestinal Neoplasms|Adenocarcinoma|Neuroblastoma|Ovarian Neoplasms|Sarcoma|Adrenocortical Carcinoma|Wilms Tumor|Rhabdomyosarcoma|Desmoplastic Small Round Cell Tumor | Drug: CHPP of Cisplatin|Procedure: Abdominal Surgery | https://ClinicalTrials.gov/show/NCT00436657 |
| 162149 | 162149 | Lapatinib and Topotecan in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Did Not Respond to Cisplatin or Carboplatin | Completed | Has Results | Ovarian Cancer|Peritoneal Cavity Cancer | Drug: Lapatinib|Drug: Topotecan | https://ClinicalTrials.gov/show/NCT00436644 |
| 162126 | 162126 | AZD2171 to Treat Prostate Cancer | Completed | Has Results | Prostate Cancer | Procedure: Magnetic Resonance Imaging (DCE-MRI)|Drug: AZD2171|Drug: Prednisone | https://ClinicalTrials.gov/show/NCT00436956 |
| 162127 | 162127 | Smoking Cessation Program: A Quality Improvement Trial in a Resident-Based Outpatient Clinic | Terminated | No Results Available | Smoking | Drug: nicotine replacement therapy and bupropion|Behavioral: smoking cessation counseling and referrals | https://ClinicalTrials.gov/show/NCT00436943 |
| 162128 | 162128 | Vaccine Therapy and GM-CSF in Treating Patients With Recurrent or Metastatic Melanoma | Completed | No Results Available | Melanoma (Skin) | Biological: autologous tumor cell vaccine|Biological: sargramostim|Biological: therapeutic autologous dendritic cells | https://ClinicalTrials.gov/show/NCT00436930 |
| 162129 | 162129 | Zoledronate in Treating Osteopenia or Osteoporosis in Postmenopausal Women Receiving Letrozole for Stage I, Stage II, or Stage IIIA Primary Breast Cancer | Active, not recruiting | Has Results | Breast Cancer|Osteoporosis | Drug: zoledronic acid|Procedure: Letrozole as adjuvant therapy | https://ClinicalTrials.gov/show/NCT00436917 |
| 162130 | 162130 | Alemtuzumab and Rituximab in Treating Patients With High-Risk, Early-Stage Chronic Lymphocytic Leukemia | Completed | Has Results | Leukemia | Drug: Alemtuzumab|Drug: Rituximab | https://ClinicalTrials.gov/show/NCT00436904 |
| 162131 | 162131 | Streptococcal Infections in Fiji - Prevalence of Group A Streptococcal Pyoderma and Scabies in Infants in Fiji | Completed | No Results Available | Streptococcus Group A | | https://ClinicalTrials.gov/show/NCT00436891 |
| 162132 | 162132 | Intake Promoting Effects of Large Portions in Children | Recruiting | No Results Available | Food Intake | Behavioral: Food portion size | https://ClinicalTrials.gov/show/NCT00436878 |
| 162133 | 162133 | Insulin and the Polycystic Ovary Syndrome--Weight Reduction Study | Recruiting | No Results Available | Polycystic Ovary Syndrome|Obesity | Behavioral: Weight loss | https://ClinicalTrials.gov/show/NCT00436865 |
| 162134 | 162134 | ABT-751 in Treating Children With Neuroblastoma That Has Relapsed or Not Responded to Previous Treatment | Active, not recruiting | Has Results | Disseminated Neuroblastoma|Recurrent Neuroblastoma | Drug: ABT-751|Procedure: quality-of-life assessment | https://ClinicalTrials.gov/show/NCT00436852 |
| 162135 | 162135 | Taxotere Prostate Cancer New Indication Registration Trial in China | Completed | No Results Available | Prostatic Neoplasms | Drug: Docetaxel|Drug: Mitoxantrone|Drug: Prednisone | https://ClinicalTrials.gov/show/NCT00436839 |
| 162136 | 162136 | A Phase 2 Study of Cladribine Add-on to Interferon-beta (IFN-beta) Therapy in Multiple Sclerosis (MS) Subjects With Active Disease (ONWARD) | Completed | Has Results | Multiple Sclerosis | Drug: Cladribine|Drug: Placebo|Drug: Interferon-beta (IFN-beta) | https://ClinicalTrials.gov/show/NCT00436826 |
| 162150 | 162150 | Internet Administration of the Modified Atkins Diet for Adults With Intractable Epilepsy | Completed | No Results Available | Epilepsy | Behavioral: Dietary management of seizures | https://ClinicalTrials.gov/show/NCT00436631 |